Exxon Mobil (XOM) fell out of the gate Wednesday after the energy giant warned investors that lower oil prices and refining margins will impact its fourth-quarter earnings, which will be released later this month.
In an 8-K filing with the Securities and Exchange Commission (SEC), Exxon Mobil said that it expects upstream earnings to decline by $500 million to $900 million from the third quarter due to declining liquid prices, according to MarketWatch.
Additionally, lower margins are expected to reduce its energy products earnings by $300 million to $700 million and its chemical products earnings by $300 million to $500 million.
From just $107.88 $24.99 for Kiplinger Personal Finance
Become a smarter, better informed investor. Subscribe from just $107.88 $24.99, plus get up to 4 Special Issues
Sign up for Kiplinger’s Free Newsletters
Profit and prosper with the best of expert advice on investing, taxes, retirement, personal finance and more - straight to your e-mail.
Profit and prosper with the best of expert advice - straight to your e-mail.
One positive is in its upstream segment, where higher gasoline prices are expected to increase earnings by up to $400 million.
Mizuho analyst Nitin Kumar responded by lowering his fourth-quarter earnings-per-share (EPS) forecast by 13% to $1.55. The analyst has a Neutral (Hold) rating on the energy stock.
MarketWatch noted that Exxon's warning came just a day after oil and gas company Shell (SHEL) gave a similar outlook in a 6-K filing.
Exxon said it expects to report its fourth-quarter earnings before the market opens on Friday, January 31.
Is Exxon Mobil stock a buy, sell or hold?
Exxon Mobil has lagged the broader market over the past 12 months, up 9.6% on a total return basis (price change plus dividends) vs the S&P 500's 27.5% gain. Yet, Wall Street remains bullish on the top dividend stock.
According to S&P Global Market Intelligence, the average analyst target price for XOM stock is $129.94, representing implied upside of about 21% to current levels. Meanwhile, the consensus recommendation is Buy.
Financial services firm UBS Global Research is one of the more bullish outfits on the blue chip stock with a Buy rating and a $147 price target.
In a note following the release of Exxon's 8-K filing, UBS Global Research analyst Josh Silverstein noted that the filing did "not include impacts from factors that have historically benefited XOM, including its growing Upstream volumes, ongoing cost reduction efforts, and its shift towards higher-value Downstream products."
However, he added that his firm may review its estimates following a discussion with Exxon.
Related content
-
I'm want to give my 3 grandkids $5K each for Christmas.You're comfortably retired and want to give your grandkids a big Christmas check, but their parents are worried they might spend it all. We ask the pros for help.
-
If You're Not Doing Roth Conversions, You Need to Read ThisRoth conversions and other Roth strategies can be complex, but don't dismiss these tax planning tools outright. They could really work for you and your heirs.
-
Could Traditional Retirement Expectations Be Killing Us?A retirement psychologist makes the case: A fulfilling retirement begins with a blueprint for living, rather than simply the accumulation of a large nest egg.
-
Stocks Close Out Strong Month With Solid Amazon Earnings: Stock Market TodayAmazon lifted its spending forecast as its artificial intelligence (AI) initiatives create "a massive opportunity."
-
Stocks Close September on a High Note: Stock Market TodayA little bit of late risk-on behavior was enough to lift stocks into the green on the last day of September.
-
How to Invest for Rising Data Integrity RiskAmid a broad assault on venerable institutions, President Trump has targeted agencies responsible for data critical to markets. How should investors respond?
-
What Tariffs Mean for Your Sector ExposureNew, higher and changing tariffs will ripple through the economy and into share prices for many quarters to come.
-
Dow Dives 542 Points on Soft Jobs Data: Stock Market TodayThe last day of a busy week ends with the first greater-than-1% move in either direction in more than a month.
-
Stock Market Today: Dow Leads as UnitedHealth Stock PopsUnitedHealth was the best Dow Jones stock Monday on reports that Medicare Advantage payments could rise in 2026.
-
Stock Market Today: Stocks End Mixed After FOMC MinutesThe minutes from the December Fed meeting signaled central bankers' uncertainty over potential Trump administration policies.
-
Stock Market Today: Stocks Renew Rally Ahead of Mag 7 EarningsThe Dow Jones led the major indexes higher on the strength of old-school industrial stalwart 3M.
